MACKANESS JAMES H (Chief Financial Officer) sold 6.6% of their position (7.87K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $360.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/6/2025ACC: 0001415889-25-000955
Officer· Chief Financial Officer
Since Nov 2019
-7.87K
Net shares
Net seller
$360.5K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
7.87K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.76K
Price / share
$45.37
Trade value
$170.67K
% of position
3.2%
1/2/2025
119.17K→115.41K
Common Stock
Direct
Shares
−321.00
Price / share
$45.92
Trade value
$14.74K
% of position
0.3%
1/2/2025
115.41K→115.09K
Common Stock
Direct
Shares
−3.79K
Price / share
$46.18
Trade value
$175.05K
% of position
3.3%
1/3/2025
115.09K→111.30K
Total
Net shares
−7.87K
Net value
-$360.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | S · Sale | −3.76K | $45.37 | $170.67K | 3.2% | 119.17K | 115.41K |
| Common Stock Direct | 1/2/2025 | S · Sale | −321.00 | $45.92 | $14.74K | 0.3% | 115.41K | 115.09K |
| Common Stock Direct | 1/3/2025 | S · Sale | −3.79K | $46.18 | $175.05K | 3.3% | 115.09K | 111.30K |
| Total | −7.87K | -$360.46K | ||||||
Derivative Transactions0
No derivative transactions reported